May 8, 2017 / 8:57 PM / 3 months ago

BRIEF-Aeterna Zentaris qtrly loss per share $0.31

1 Min Read

May 8 (Reuters) - Aeterna Zentaris Inc:

* Aeterna Zentaris reports first quarter 2017 financial and operating results

* Aeterna Zentaris Inc - qtrly revenue $261,000 versus $242,000; qtrly loss per share $0.31

* Aeterna Zentaris Inc - do not anticipate conducting clinical trials of zoptrex with respect to any other indications

* Aeterna Zentaris Inc - co's focus has now shifted entirely to filing new drug application for macrilen Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below